Kamigyo-ku, Japan Clinical Trials

A listing of Kamigyo-ku, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 25 clinical trials
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

The main purpose of the Product Performance Report (formerly referred to as System Longevity Study) is to evaluate long-term performance of Medtronic market-released cardiac rhythm products by analyzing product survival probabilities.

 (1.4 away) Contact site
  • 30 Jul, 2021
  • +230 other locations
Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

This is a multi-center observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer(NSCLC) or extensive disease small cell lung cancer(ED-SCLC). 800 patients in NSCLC cohort and 400 patients in ED-SCLC cohort will be enrolled in this trial to assess the efficacy and …

lung carcinoma
recurrent non-small cell lung cancer
University Hospital, Kyoto Prefectural University of Medicine
 (0.9 away) Contact site
  • 02 Jul, 2021
  • +154 other locations
REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney Disease

This is a retrospective, multinational, non-interventional, observational study. A series of cohort studies will be conducted to assess the prevalence of undiagnosed stage 3 CKD in each region. The study will also assess the current state of CKD management in patients with undiagnosed CKD

Research Site
 (5.1 away) Contact site
  • 22 Jul, 2021
  • +11 other locations
Cryo Global Registry

Cryo Global Registry a prospective, global, multi-center, observational Post-Market Registry

Kyoto University Hospital
 (1.4 away) Contact site
  • 21 Jun, 2021
  • +140 other locations
Cohort Study of the Clinical Course of Macular Diseases in Japanese

Recent clinical introduction of anti-vascular endothelial growth factor agents may change the clinical course of macular diseases, including age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP), central serous chorioretinopathy (CSC), myopic choroidal neovascularization (CNV), retinal vein occlusion (RVO), diabetic macular edema (DME), and so forth. Patients …

Kyoto University Graduate School of Medicine
 (1.4 away) Contact site
  • 21 Jan, 2021
  • 1 location
Computerized Registry of Patients With Venous Thromboembolism (RIETE)

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet to help physicians to improve their knowledge on the …

pulmonary embolism
anticoagulation therapy
deep vein thrombosis
Kyoto University Hospital
 (1.4 away) Contact site
  • 16 May, 2021
  • +201 other locations
Brilinta Clinical Experience Investigation

To confirm the following safety topics in patients to be treated with BRILINTA tablets 60 mg or 90 mg (hereinafter referred to as "BRILINTA") in clinical practice in the post-marketing phase. Profile and incidence of ADRs The CEI will be conducted to collect data of the events, especially focusing on …

Research Site
 (1.4 away) Contact site
  • 18 Jul, 2021
  • +31 other locations
Forxiga HF General Drug Use-Results Study

To capture safety when Forxiga is administered to patients with HF in clinical practice after launch.

Research Site
 (5.1 away) Contact site
  • 02 Aug, 2021
  • +45 other locations
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis

The objective of this study is to investigate the safety and effectiveness in routine clinical practice and actual clinical setting for all patients with rheumatoid arthritis (RA) treated with peficitinib.

Site JP00026
 (1.4 away) Contact site
  • 02 Aug, 2021
  • +46 other locations
ADYNOVATE Drug Use-Results Survey

The purpose of this survey is to understand the following items in the actual clinical use of ADYNOVATE in patients: Unexpected adverse drug reactions Occurrence of adverse drug reactions in the actual clinical use Factors that may affect safety and efficacy Occurrence of Factor VIII inhibitor development in patients with …

factor viii inhibitor
antihemophilic factor
coagulation factor
Kyoto City
 (3.6 away) Contact site
  • 26 Jan, 2021
  • +48 other locations